Sang Rim Lee
Papers
1
Total Citations
16
H-Index
1
About
Sang Rim Lee is a leading researcher in surgical oncology and perioperative pain management, with a particular focus on gastrointestinal cancers and innovative analgesic strategies. Dr. Lee’s work bridges the gap between surgical outcomes and patient-centered care, most notably through pioneering investigations into the affective component of postoperative pain. In a landmark 2021 proof-of-concept study (16 citations), Dr. Lee evaluated VVZ-149, a novel dual-action analgesic that inhibits glycine transporter type 2 and the serotonin 5-HT2A receptor, demonstrating its potential to reduce emotional suffering after laparoscopic and robotic gastrectomy. This work represents a significant contribution to understanding how molecular interventions can target not just nociception but the psychological dimensions of recovery. Dr. Lee’s research has been instrumental in advancing personalized pain protocols for gastric cancer patients, with implications for enhanced recovery after surgery (ERAS) pathways. By integrating mechanistic pharmacology with rigorous clinical trial design, Dr. Lee has helped shape a new paradigm where surgical innovation and analgesic development converge to improve both physical and emotional outcomes for patients undergoing major abdominal procedures.
Research Focus
Key Achievements
Top Papers
- 1